Company Filing History:
Years Active: 2025
Title: Weihui Zhong: Innovator in Drug Synthesis
Introduction
Weihui Zhong is a notable inventor based in Jiaxing, China. He has made significant contributions to the field of drug synthesis, particularly through his innovative methods in preparing pharmaceutical intermediates. His work is characterized by a focus on improving the efficiency and quality of drug synthesis processes.
Latest Patents
Weihui Zhong holds a patent for a method titled "Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as intermediate of halofuginone." This patent describes a novel approach to synthesizing trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone, which is crucial for the production of halofuginone. The method utilizes amino-substituted pentanal and a thiazolyl sulfoxide compound as raw materials, employing Mislow-Evans rearrangement reaction and subsequent Lewis acid catalysis. This innovative technique achieves high yields and stable qualities, providing a new reference route for synthesis while avoiding the use of expensive metal catalysts.
Career Highlights
Weihui Zhong is associated with Chengda Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Weihui Zhong has collaborated with notable colleagues, including Yu Feng and Hong Xu. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.
Conclusion
Weihui Zhong's contributions to drug synthesis exemplify the impact of innovative thinking in the pharmaceutical field. His patented methods and collaborative efforts continue to influence the industry positively.